Molecular Neurodegeneration

Scope & Guideline

Pioneering discoveries in cellular and molecular neuroscience.

Introduction

Welcome to your portal for understanding Molecular Neurodegeneration, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN-
PublisherBMC
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationMOL NEURODEGENER / Mol. Neurodegener.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

Molecular Neurodegeneration focuses on the molecular and cellular mechanisms underlying neurodegenerative diseases, providing a platform for research that integrates various aspects of neurobiology and pathology.
  1. Mechanistic Insights into Neurodegeneration:
    The journal emphasizes understanding the fundamental biological processes that lead to neurodegenerative diseases, such as Alzheimer's, Parkinson's, and other tauopathies. This includes studies on protein misfolding, aggregation, and cellular stress responses.
  2. Immune System Interactions:
    Research often explores the role of the immune system, including microglial activation, neuroinflammation, and the effects of immune modulation on neurodegeneration, highlighting the complex interplay between the nervous and immune systems.
  3. Genetic and Epigenetic Factors:
    The journal covers genetic studies, including genome-wide association studies (GWAS) and investigations into specific genetic variants that contribute to neurodegenerative conditions, as well as epigenetic mechanisms that influence disease progression.
  4. Therapeutic Approaches and Biomarkers:
    Molecular Neurodegeneration presents studies on novel therapeutic strategies, including drug development, immunotherapy, and biomarker identification, aimed at improving diagnosis and treatment outcomes for neurodegenerative diseases.
  5. Cellular and Animal Models:
    The use of advanced cellular and animal models to study disease mechanisms and test therapeutic interventions is a consistent theme, allowing for a better understanding of human neurodegenerative conditions.
Recent publications in Molecular Neurodegeneration highlight several emerging themes that reflect the evolving landscape of neurodegenerative research.
  1. Role of the Gut-Brain Axis:
    There is an increasing focus on the gut microbiome's influence on neurodegeneration, particularly how gut-derived metabolites and inflammation affect brain health and disease progression.
  2. Single-Cell and Multi-Omics Approaches:
    The application of single-cell sequencing and multi-omics strategies is gaining traction, enabling researchers to dissect cellular heterogeneity and molecular pathways involved in neurodegenerative diseases.
  3. Targeted Protein Degradation:
    Emerging strategies involving targeted protein degradation technologies (e.g., AUTOTAC) are being explored as potential therapeutic approaches for clearing pathological protein aggregates.
  4. Advances in RNA Therapeutics:
    Research on RNA-based therapies, including antisense oligonucleotides and RNA modulation techniques, is on the rise, reflecting a shift towards innovative therapeutic modalities.
  5. Neuroinflammation and Microglial Function:
    A significant trend is the deeper exploration of neuroinflammation and the diverse roles of microglia in neurodegeneration, including their contributions to disease progression and potential as therapeutic targets.

Declining or Waning

While certain themes remain strong, others appear to be declining in prominence, reflecting shifts in research focus within the field of neurodegeneration.
  1. Traditional Neuropathology Studies:
    There seems to be a reduced emphasis on classical histopathological studies of neurodegenerative diseases, as research increasingly favors molecular and genetic approaches.
  2. Simple Model Systems:
    The use of basic model organisms or systems that do not adequately recapitulate human disease pathology appears to be waning, with a shift towards more complex models that better mimic human neurodegenerative processes.
  3. Generalized Biomarker Research:
    Research focused solely on generalized biomarkers without specific context or mechanistic insights is becoming less common, as the field moves towards more targeted and disease-specific biomarker studies.
  4. Broad Immunotherapy Approaches:
    There is a noticeable decline in publications focusing on broad-spectrum immunotherapies, with a shift towards more specific and mechanism-based immunomodulatory strategies.

Similar Journals

ASN Neuro

Connecting Researchers to Transformative Neuroscience Insights
Publisher: FRONTIERS MEDIA SAISSN: 1759-0914Frequency: 1 issue/year

ASN Neuro is an esteemed academic journal published by Frontiers Media SA, focusing on critical advancements in the fields of neurology and neuroscience. Since its inception in 2009, it has established itself as an Open Access platform dedicated to fostering the dissemination of knowledge and research findings that address the complexities of the nervous system. With an impressive impact factor and consistently ranking in the top quartiles of its categories—Q1 in Neurology (clinical) and Q2 in Neuroscience (miscellaneous)—ASN Neuro is recognized for its high-quality publications that cater to the evolving challenges in clinical neurology and general neuroscience. Currently, it ranks 68th out of 400 journals in Clinical Neurology and 28th out of 113 in General Neuroscience, affirming its reputable position within the academic community. Researchers, professionals, and students alike are encouraged to contribute to and benefit from this impactful journal as it presents a unique opportunity to engage with cutting-edge research, innovative methodologies, and insightful reviews in the ever-evolving landscape of brain science.

ACS Chemical Neuroscience

Exploring the Chemistry of the Mind.
Publisher: AMER CHEMICAL SOCISSN: 1948-7193Frequency: 12 issues/year

ACS Chemical Neuroscience, published by the American Chemical Society, is a premier journal dedicated to exploring the complex interactions between chemistry and neuroscience. With its ISSN 1948-7193 and a distinguished impact factor that positions it within the top quartiles across multiple categories, including Q1 in Biochemistry, Q2 in Cell Biology, and Q1 in Physiology, this journal serves as an essential platform for researchers engaged in cutting-edge studies from 2010 to 2024. Positioned within the top 15% of its field in Cognitive Neuroscience according to Scopus rankings, ACS Chemical Neuroscience strives to foster interdisciplinary collaboration, publishing significant advancements that integrate chemical concepts with neurological processes. Despite its traditional publication model, the journal is committed to maintaining rigorous peer-review standards and providing valuable insights that drive innovations in therapeutics and understanding the biochemical underpinnings of brain function. Researchers, professionals, and students alike will find in this journal a vital resource for the latest findings and methodologies in the dynamic intersection of chemistry and neuroscience.

JOURNAL OF MOLECULAR NEUROSCIENCE

Pioneering Research in Cellular and Molecular Neuroscience
Publisher: SPRINGERNATUREISSN: 0895-8696Frequency: 9 issues/year

Journal of Molecular Neuroscience, published by SpringerNature, is a critical resource for researchers and professionals in the dynamic field of neuroscience. With ISSN 0895-8696 and E-ISSN 1559-1166, this journal has established itself as a key player since its inception in 1989, covering a range of topics within Cellular and Molecular Neuroscience and Medicine (miscellaneous). Its impressive rankings, including being placed in the Q2 quartile for Medicine and Q3 for Cellular and Molecular Neuroscience, underscore its scholarly impact, featuring innovative research that informs and advances our understanding of neural processes. The journal does not currently operate under an open-access model, providing rich, peer-reviewed content geared towards academics and professionals seeking comprehensive analyses and breakthroughs in molecular neurobiology. With a publication window extending to 2024, the Journal of Molecular Neuroscience remains dedicated to enhancing the scientific community's knowledge landscape, making it an essential reference for those passionate about unraveling the complexities of the nervous system.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

Transforming Understanding through Neurobiological Advances
Publisher: WILEYISSN: 0305-1846Frequency: 7 issues/year

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY is a premier journal dedicated to advancing the understanding of the intricate relationships between pathology and neurobiology. Published by Wiley since 1975, this journal has established itself as a crucial resource for researchers, clinicians, and students interested in the latest insights and developments in the fields of pathology, neurology, and neuroscience. With an impressive history of convergence extending to 2024, it boasts a Q1 ranking in multiple categories including Histology, Neurology, and Pathology, reflecting its high impact and reputation in the academic community. Additionally, it ranks 18th out of 208 in Pathology and Forensic Medicine with a remarkable 91st percentile, signifying its relevance and influence in medical research. While not open access, this journal provides valuable content that contributes significantly to the ongoing discourse in neurobiological advancements and is a vital reference for those engaged in this dynamic field.

SYNAPSE

Fostering Innovation in Neuroscience Research
Publisher: WILEYISSN: 0887-4476Frequency: 12 issues/year

SYNAPSE, an esteemed journal in the field of Cellular and Molecular Neuroscience, is published by Wiley and serves as a vital platform for disseminating groundbreaking research in neuroscience. Established in 1987, this journal has been pivotal in exploring the intricate mechanisms governing synaptic function and neural communication, contributing to our understanding of the nervous system. With an ISSN of 0887-4476 and an E-ISSN of 1098-2396, SYNAPSE is indexed in Scopus and currently holds a Q4 quartile ranking in its category, reflecting its niche yet significant presence within the research community. Despite its recent ranking in the 21st percentile among its peers, the journal’s commitment to quality and innovation remains unwavering. It is published from Hoboken, New Jersey, and although it is not an open-access journal, it provides invaluable insights and critical reviews that are pivotal for researchers, professionals, and students alike who seek to advance their knowledge in the dynamic field of neuroscience. Join us in contributing to the ever-evolving discourse in cellular and molecular neuroscience through SYNAPSE.

NEUROCHEMISTRY INTERNATIONAL

Elevating Knowledge in the Realm of Neurochemistry
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0197-0186Frequency: 10 issues/year

NEUROCHEMISTRY INTERNATIONAL, published by Pergamon-Elsevier Science Ltd, offers a premier platform for researchers and professionals in the realms of cell biology and cellular and molecular neuroscience. Established in 1980 and continuing its passion for advancing the field, this esteemed journal enhances scientific collaboration with a notable 2023 Q2 ranking in both relevant categories, placing it among the top-tier publications in its discipline with a Scopus rank of 23/97 for Cellular and Molecular Neuroscience. With its focus on groundbreaking research, the journal provides a wealth of vital data and insights that drive forward our understanding of neurochemistry and its implications in health and disease. While not an Open Access journal, NEUROCHEMISTRY INTERNATIONAL is integral for professionals, academics, and students aiming to stay at the forefront of neurobiological research innovations, making significant contributions to both academia and clinical applications.

ACTA NEUROBIOLOGIAE EXPERIMENTALIS

Bridging Research and Clinical Applications in Neuroscience
Publisher: NENCKI INST EXPERIMENTAL BIOLOGYISSN: 0065-1400Frequency: 4 issues/year

ACTA NEUROBIOLOGIAE EXPERIMENTALIS, an esteemed journal published by the Nencki Institute of Experimental Biology in Poland, has been a pivotal platform for the dissemination of research in the fields of medicine and neuroscience since its inception in 1970. With an ISSN of 0065-1400 and an E-ISSN of 1689-0035, this journal has consistently aimed to contribute to the understanding of neurobiological phenomena, cementing its status within the academic community. Despite its current categorization in the Q3 and Q4 quartiles for Medicine and Neuroscience respectively, ACTA NEUROBIOLOGIAE EXPERIMENTALIS continues to uphold rigorous scientific standards, providing an invaluable resource for researchers, professionals, and students alike. As an essential scholarly outlet, it encourages the exploration of groundbreaking findings and clinical applications in neurobiology, making it an attractive choice for those eager to advance their understanding of this intricate field.

NEUROMOLECULAR MEDICINE

Advancing the Frontiers of Neuroscience and Molecular Medicine
Publisher: HUMANA PRESS INCISSN: 1535-1084Frequency: 4 issues/year

NEUROMOLECULAR MEDICINE, published by HUMANA PRESS INC, is a prestigious peer-reviewed journal dedicated to advancing the fields of cellular and molecular neuroscience, molecular medicine, and neurology. With an ISSN of 1535-1084 and an E-ISSN of 1559-1174, the journal boasts a significant presence in academic research since its inception in 2002 and continues to publish cutting-edge studies through 2024. Ranked in the Q2 category for 2023 in various disciplines, including Neuroscience and Molecular Medicine, it holds impressive positions in Scopus rankings, including 41st out of 192 in Neuroscience and Neurology. Although not an open access journal, NEUROMOLECULAR MEDICINE remains invaluable for researchers, professionals, and students seeking to explore the intricate relationships between molecular mechanisms and neurological functions, thereby contributing to the scientific understanding of nervous system diseases and therapeutic innovations.

CELLULAR AND MOLECULAR NEUROBIOLOGY

Fostering Collaboration for a Deeper Understanding of Neurobiology.
Publisher: SPRINGER/PLENUM PUBLISHERSISSN: 0272-4340Frequency: 8 issues/year

CELLULAR AND MOLECULAR NEUROBIOLOGY, published by SPRINGER/PLENUM PUBLISHERS, stands as a significant contributor to the fields of cell biology and neuroscience, holding a distinguished position in the academic community with an impact factor that places it in the Q2 category for both Cell Biology and Cellular and Molecular Neuroscience, along with Q1 in Medicine (miscellaneous). Since its inception in 1981, this journal has provided a critical platform for innovative research and thought-provoking reviews, fostering a deeper understanding of complex neurobiological mechanisms. The journal’s rigorous peer-review process ensures the publication of high-quality manuscripts that offer valuable insights into cellular processes and neural functions. With a commitment to advancing knowledge and promoting collaboration among researchers, CELLULAR AND MOLECULAR NEUROBIOLOGY remains an essential resource for professionals and students alike, looking to stay updated on the latest developments in neurobiology.

CELL STRESS & CHAPERONES

Fostering Interdisciplinary Dialogue on Cellular Mechanisms
Publisher: SPRINGERISSN: 1355-8145Frequency: 4 issues/year

CELL STRESS & CHAPERONES is a renowned journal that has been at the forefront of advancing our understanding of protein folding, cellular stress responses, and the role of chaperone proteins since its inception in 1996. Published by SPRINGER, this esteemed journal operates out of the Netherlands and serves as a critical platform for researchers in the fields of Biochemistry and Cell Biology. With an impressive impact factor reflecting its credibility—ranked Q2 in Biochemistry and Q3 in Cell Biology for 2023—it showcases rigorous, peer-reviewed research that contributes significantly to the understanding of cellular mechanisms and their implications in health and disease. The journal's commitment to disseminating high-quality research is evident through its indexed status ranking in the Scopus database, identifying it among the top quartile of publications in its respective categories. For scholars and practitioners dedicated to exploring the intricate relationship between cellular stress and physiological responses, CELL STRESS & CHAPERONES provides a vital resource, fostering an interdisciplinary dialogue that enhances the scientific community's collective knowledge.